FDA Adverse Event Malfunction Summary report: N

SYNCHROMED II

MDR report key: 3067703 · Received April 19, 2013

Report

Report Number
3007566237-2013-01351
Event Type
Malfunction
Date Received
April 19, 2013
Report Date
March 21, 2013
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

CONCOMITANT PRODUCTS: PRODUCT ID 8575, LOT# N061703, IMPLANTED: (B)(6) 2006, PRODUCT TYPE ACCESSORY; PRODUCT ID 8709, LOT# J0039955R, IMPLANTED: (B)(6) 2000, PRODUCT TYPE CATHETER; PRODUCT ID 8709, LOT# J0039955R, IMPLANTED: (B)(6) 2000, PRODUCT TYPE CATHETER. (B)(4). ANALYSIS OF THE PUMP FOUND NO SIGNIFICANT ANOMALY. ELECTIVE REPLACEMENT INDICATOR (ERI) WAS NOTED DUE TO TIME PROGRESSION.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PUMP WAS EXPLANTED DUE TO EOL (END OF LIFE). IT WAS LATER REPORTED THAT ON (B)(6) 2012 THERE WAS AN INABILITY TO ASPIRATE FLUID; NO FREE FLOW OF CSF. ON (B)(6) 2012 AND ISOTOPE PUMP STUDY SHOWED 'NORMAL DELIVERY OF DRUG.' THE PUMP WAS REPLACED ON (B)(6) 2013. THE PATIENT HAD NO SIGNS OR SYMPTOMS. THE DEVICE SYSTEM WAS DELIVERING MORPHINE, CLONIDINE, BUPIVACAINE, AND BACLOFEN. IT WAS LATER REPORTED THAT WHEN THE PATIENT WAS TAKEN INTO THE OR FOR THE BATTERY REPLACEMENT, THE PUMP WAS DISCONNECTED FROM THE CATHETER, BUT THERE NO FREE FLOW OF CSF OBTAINED. A BACK TABLE FILL OF THE NEW PUMP WAS DONE AND THE CATHETER WAS LEFT IN PLACE. IT WAS LATER REPORTED THAT THE PATIENT RECOVERED WITHOUT SEQUELA.

Description of Event or Problem · 1

IT WAS PREVIOUSLY REPORTED THAT THE PATIENT WAS TO BE SEEN FOR A POSTOPERATIVE VISIT "NEXT WEEK" TO CHECK THE WOUND TO RESOLVE THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
170774 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION 863740

Patients

Seq Age Sex Outcome Treatment
1 00052 YR